HALOZYME THERAPEUTICS, INC. (HALO)

SEC filing

HALOZYME THERAPEUTICS, INC.

HALO · CIK 1159036

4 · Dec 19, 2025 · Caudill Cortney sold 4,263 shares at $65.19/share ($277.9K); exercised options for 9,326 shares

Caudill Cortney sold 4,263 shares at $65.19/share ($277.9K); exercised options for 9,326 shares

FORM 4

xslF345X05/wk-form4_1766183980.xmlSEC.gov

Graphics and non-inline formats (not embedded below).